1228689-61-9

Basic information

• Product Name: 4-Isoxazolecarboxylic acid, 5-(4-broMophenyl)-3-Methyl-, Methyl ester
• Synonyms: 4-Isoxazolecarboxylic acid, 5-(4-broMophenyl)-3-Methyl-, Methyl ester;methyl 5-(4-bromophenyl)-3-methyl-isoxazole-4-carboxylate
• CAS NO: 1228689-61-9
• Molecular Formula: C₁₂H₁₀BrNO₃
• Molecular Weight: 296.1167
• Mol File: 1228689-61-9.mol
• Article Data: 9

Chemical Properties

• Boiling Point: 403.9±45.0 °C(Predicted)
• Appearance: /
• Density: 1.472±0.06 g/cm3(Predicted)
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: -4.39±0.50(Predicted)
• CAS DataBase Reference: 4-Isoxazolecarboxylic acid, 5-(4-broMophenyl)-3-Methyl-, Methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Isoxazolecarboxylic acid, 5-(4-broMophenyl)-3-Methyl-, Methyl ester(1228689-61-9)
• EPA Substance Registry System: 4-Isoxazolecarboxylic acid, 5-(4-broMophenyl)-3-Methyl-, Methyl ester(1228689-61-9)

Safety Data

• Hazardous Substances Data: 1228689-61-9(Hazardous Substances Data)

Usage

General Description

4-Isoxazolecarboxylic acid, 5-(4-bromophenyl)-3-methyl-, methyl ester is a chemical compound with the molecular formula C12H11BrN2O3. It is a methyl ester derivative of 4-isoxazolecarboxylic acid and contains a 4-bromophenyl and 3-methyl group. 4-Isoxazolecarboxylic acid, 5-(4-bromophenyl)-3-methyl-, methyl ester is often used in the field of organic chemistry and pharmaceutical research due to its potential biological and pharmacological activities. It may have applications in the development of new drugs or as a building block in organic synthesis. The specific properties and potential uses of 4-Isoxazolecarboxylic acid, 5-(4-bromophenyl)-3-methyl-, methyl ester are still being actively researched.

Upstream product

• 1423699-80-2 C₁₃H₁₄BrNO₃ 
• 586-75-4 4-chlorobenzoyl chloride 
• 586-76-5 4-Bromobenzoic acid 
• 13412-12-9 3-methylaminobut-2-enoic acid methyl ester 
• 105-45-3 acetoacetic acid methyl ester 
• 85963-90-2 methyl 2-(4-bromobenzoyl)-3-oxo-butanoate 
• 1229193-57-0 2-(4-bromo-benzoyl)-3-[(E)-methylimino]-butyric acid methyl ester 

Downstream Products

• 1280205-98-2 (5-(4-bromophenyl)-3-methylisoxazole-4-yl)methanol 
• 1267684-96-7 5-(4-bromophenyl)-3-methylisoxazole-4-carbaldehyde 
• 1280206-27-0 1-[4'-(4-hydroxymethyl-3-methyl-isoxazol-5-yl)-biphenyl-4-yl]-cyclopropanecarboxylic acid ethyl ester 
• 1280206-29-2 1-[4'-(4-bromomethyl-3-methyl-isoxazol-5-yl)-biphenyl-4-yl]-cyclopropanecarboxylic acid ethyl ester 
• 1280206-15-6 4-bromomethyl-5-(4-bromo-phenyl)-3-methyl-isoxazole 
• 1280206-16-7 [5-(4-Bromo-phenyl)-3-methyl-isoxazol-4-yl]-acetonitrile 
• 1280206-14-5 [5-(4-bromo-phenyl)-3-methyl-isoxazol-4-yl]-acetic acid 
• 1280206-18-9 [5-(4-bromo-phenyl)-3-methyl-isoxazol-4-yl]-acetic acid ethyl ester 
• 1280732-36-6 [5-(4-bromo-phenyl)-3-methyl-isoxazol-4-yl]-acetic acid hydrazide 
• 1280732-37-7 2-[5-(4-bromo-phenyl)-3-methyl-isoxazol-4-ylmethyl]-5-phenyl-[1,3,4]oxadiazole 
• 1280732-55-9 5-(4-bromo-phenyl)-3-methyl-isoxazole-4-carboxylic acid hydrazide 
• 1280206-91-8 1-[4'-(4-Formyl-3-methyl-isoxazol-5-yl)-biphenyl-4-yl]-cyclopropanecarboxylic acid ethyl ester 
• 1280732-66-2 (5-benzyl-[1,3,4]oxadiazol-2-yl)-[5-(4-bromo-phenyl)-3-methyl-isoxazol-4-yl]-methanol 
• 1280733-16-5 (3-benzyl-phenyl)-[5-(4-bromo-phenyl)-3-methyl-isoxazol-4-yl]-methanol 

Relevant articles and documents

LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS

Compounds, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds to treat, prevent or diagnose diseases, disorders, or conditions associated with one or more of the lysophosphatidic acid receptors are provided.

LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS

Described herein are compounds that are antagonists of lysophosphatidic receptor(s). Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such antagonists, alone and in com

Compounds as Lysophosphatidic Acid Receptor Antagonists

Described herein are compounds that are antagonists of lysophosphatidic receptor(s). Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such antagonists, alone and in com